President Donald Trump has announced plans for a $100 million federal investment in a drug manufacturing site in Kentucky. He made the announcement during a rally in Highland Heights on Saturday. He also linked the plan to the outcome of the November elections.
Trump said the Department of War would provide the funds to help revive a large drug manufacturing facility in Winchester, Kentucky. He told the crowd that the project would bring new life to the site.
The president also warned that the investment would not go ahead if Democrats gained power. His remarks made the proposed project part of his wider campaign message ahead of the midterm vote.
The visit was part of Trump’s campaign support for Andy Barr, a Republican candidate for the U.S. Senate. Barr joined the president at the event and spoke about jobs and investment across Kentucky.
Trump said his administration was working to bring more drug production back to the United States. He claimed that pharmaceutical companies were planning to invest $600 billion in the country.
“Pharmaceutical companies are building $600 billion. We’re going to make all our drugs here,” Trump said.
His comments reflect a wider effort by the administration to expand domestic production of medicines. Supporters say local manufacturing can help create jobs and reduce reliance on overseas suppliers. It may also help the country respond to supply problems during a crisis.
However, the planned $100 million project in Winchester will depend on the details of the investment. The announcement did not provide a timeline for the work, the number of jobs expected or the full plan for the facility’s return to production.
Barr used his remarks to highlight other major investments in Kentucky. He pointed to projects linked to GE Appliances and Ford, saying they had brought jobs and economic activity to the state.
He also praised the administration’s support for coal miners. Kentucky has a long history of coal production, and the industry remains an important issue in many local communities.
Barr said the projects showed the value of investment in manufacturing and energy. He presented them as part of a broader effort to support workers and businesses across the state.
The Republican candidate also highlighted a proposed $100 billion private investment in an energy hub in western Kentucky. The project was cited as another example of plans to expand industrial activity and energy production.
The drug plant proposal and the energy project cover different parts of the economy. One focuses on medicine production, while the other is linked to energy infrastructure. Both were used at the rally to stress the role of investment in job creation.
For Kentucky, the Winchester facility could become an important part of the state’s manufacturing sector if the plan moves forward. Drug production requires skilled workers, reliable supply chains and strict quality controls. A major revival could bring new activity to the local area.
Still, the scale of the project’s impact will depend on how the funds are used and whether the site can return to full operation. Details about the facility’s ownership, production plans and hiring needs were not provided in Trump’s remarks.
The president’s announcement also comes as drug manufacturing has become a key issue in U.S. economic and national security policy. Many medicines rely on supply chains that cross national borders. Any disruption can create shortages or raise costs for health providers and patients.
Expanding domestic production is one way the administration aims to address those concerns. Yet building or reopening a drug plant can take time. Companies must meet federal safety rules and prove that their products meet quality standards before medicines can reach the market.
Trump’s remarks placed the proposed Kentucky investment within a wider campaign argument about jobs, industry and political control. He said the project depended on Republicans winning in November, while Barr highlighted investments in appliances, cars, energy and drug production.
The announcement now leaves key questions about timing, funding and the number of jobs that may be created. Until further details are released, the $100 million plan remains a pledge to revive the Winchester drug manufacturing site.
The project could add to Kentucky’s industrial base if it moves ahead. Its final effect will depend on the investment plan, the facility’s ability to resume production and the demand for the medicines it will make.
